Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy

作者: Marcus Czabanka , Mara Vinci , Frank Heppner , Axel Ullrich , Peter Vajkoczy

DOI: 10.1002/IJC.24019

关键词:

摘要: Current clinical protocols favor a combination of antiangiogenic/antivascular compounds with classical chemotherapy. However, it remains unclear to what extent an therapy influences the delivery Therefore, aim present study was characterize effects antiangiogenic tyrosine kinase inhibitor sunitinib on tumor microhemodynamics and SF126 cells were implanted subcutaneously into nude mice analyzed repeatedly by intravital microscopy. Treatment initiated 7 days after implantation. To assess vasculature hemodynamics, we total functional vessel densities, microvascular diameter, blood flow rate. chemotherapy, autofluorescent doxorubicin systemically administered its vascular tissue quantified. Histological analysis included endothelial cell proliferation, pericyte coverage vessels, proliferation. Sunitinib significantly suppressed growth both antivascular effects. number vessels escaped therapy. Interestingly, in these surviving treatment resulted increased rate resulting improved chemotherapy via vessels. Besides potent efficacy, results that escape leading These provide basis for potential chemosensitizing effect sunitinib.

参考文章(25)
Rakesh K. Jain, Emmanuelle di Tomaso, Dan G. Duda, Jay S. Loeffler, A. Gregory Sorensen, Tracy T. Batchelor, Angiogenesis in brain tumours Nature Reviews Neuroscience. ,vol. 8, pp. 610- 622 ,(2007) , 10.1038/NRN2175
Peter Vajkoczy, Lothar Schilling, Axel Ullrich, Peter Schmiedek, Michael D. Menger, Characterization of angiogenesis and microcirculation of high-grade glioma : An intravital multifluorescence microscopic approach in the athymic nude mouse Journal of Cerebral Blood Flow and Metabolism. ,vol. 18, pp. 510- 520 ,(1998) , 10.1097/00004647-199805000-00006
Anthony D. Yang, Todd W. Bauer, E. Ramsay Camp, Ray Somcio, Wenbiao Liu, Fan Fan, Lee M. Ellis, Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy Cancer. ,vol. 103, pp. 1561- 1570 ,(2005) , 10.1002/CNCR.20942
Judah Folkman, Angiogenesis in cancer, vascular, rheumatoid and other disease Nature Medicine. ,vol. 1, pp. 27- 31 ,(1995) , 10.1038/NM0195-27
Peter Vajkoczy, Michael D. Menger, Brigitte Vollmar, Lothar Schilling, Peter Schmiedek, K. Peter Hirth, Axel Ullrich, T.Annie T. Fong, Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy. Neoplasia. ,vol. 1, pp. 31- 41 ,(1999) , 10.1038/SJ.NEO.7900006
Robert Roskoski, Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochemical and Biophysical Research Communications. ,vol. 356, pp. 323- 328 ,(2007) , 10.1016/J.BBRC.2007.02.156
Frank Winkler, Sergey V. Kozin, Ricky T. Tong, Sung-Suk Chae, Michael F. Booth, Igor Garkavtsev, Lei Xu, Daniel J. Hicklin, Dai Fukumura, Emmanuelle di Tomaso, Lance L. Munn, Rakesh K. Jain, Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell. ,vol. 6, pp. 553- 563 ,(2004) , 10.1016/J.CCR.2004.10.011